BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22385677)

  • 1. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
    Zhou CH; Ye LP; Ye SX; Li Y; Zhang XY; Xu XY; Gong LY
    J Exp Clin Cancer Res; 2012 Mar; 31(1):18. PubMed ID: 22385677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PKR/eIF2α signaling pathway in prognosis of non-small cell lung cancer.
    He Y; Correa AM; Raso MG; Hofstetter WL; Fang B; Behrens C; Roth JA; Zhou Y; Yu L; Wistuba II; Swisher SG; Pataer A
    PLoS One; 2011; 6(11):e24855. PubMed ID: 22102852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
    Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
    Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
    Yamaji H; Iizasa T; Koh E; Suzuki M; Otsuji M; Chang H; Motohashi S; Yokoi S; Hiroshima K; Tagawa M; Nakayama T; Fujisawa T
    Cancer Immunol Immunother; 2004 Sep; 53(9):786-92. PubMed ID: 15185009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of CHP2 in the Development of Non-Small Cell Lung Cancer and Patients' Poor Prognosis.
    Xu L; Qin Y; Sun B; Wang H; Gu J; Tang Z; Zhang W; Feng J
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):678-686. PubMed ID: 33030853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).
    Piper AJ; Clark JL; Mercado-Matos J; Matthew-Onabanjo AN; Hsieh CC; Akalin A; Shaw LM
    PLoS One; 2019; 14(8):e0220567. PubMed ID: 31393907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions.
    Cooper WA; Kohonen-Corish MR; Zhuang L; McCaughan B; Kennedy C; Screaton G; Sutherland RL; Lee CS
    Cancer; 2008 Jul; 113(1):135-42. PubMed ID: 18457325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of complement factor I in lung cancer cells associates with shorter survival-Potentially via non-canonical mechanism.
    Felberg A; Bieńkowski M; Stokowy T; Myszczyński K; Polakiewicz Z; Kitowska K; Sądej R; Mohlin F; Kuźniewska A; Kowalska D; Stasiłojć G; Jongerius I; Spaapen R; Mesa-Guzman M; Montuenga LM; Blom AM; Pio R; Okrój M
    Transl Res; 2024 Jul; 269():1-13. PubMed ID: 38395390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic arsenic exposure enhances metastatic potential via NRF2-mediated upregulation of SOX9.
    Schmidlin CJ; Zeng T; Liu P; Wei Y; Dodson M; Chapman E; Zhang DD
    Toxicol Appl Pharmacol; 2020 Sep; 402():115138. PubMed ID: 32682831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
    Ramnath N; Tan D; Li Q; Hylander BL; Bogner P; Ryes L; Ferrone S
    Cancer Immunol Immunother; 2006 Aug; 55(8):891-9. PubMed ID: 16187081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Human Aspartyl (Asparaginyl) β-hydroxylase in NSCLC: Its Diagnostic Value by Means of Exosomes of Bronchoalveolar Lavage.
    Zhu H; Liu H; Wen J; Yuan T; Ren G; Jiang Y; Yuan Y; Mei J; Yu Y; Li G
    Appl Immunohistochem Mol Morphol; 2021 Nov-Dec 01; 29(10):720-727. PubMed ID: 34433181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of SOX9 and β-catenin expression in pre-neoadjuvant chemotherapy cases of osteosarcoma: molecular and immunohistochemical study.
    Hassan SA; Shabaan AAA; Ahmed AR; Issa YA; Fadel SH; El-Sabaa BM
    J Histotechnol; 2023 Sep; 46(3):127-138. PubMed ID: 37013797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Lipid Profiles in Human Non-Small Cell Lung Cancer.
    Jianyong Z; Yanruo H; Xiaoju T; Yiping W; Fengming L
    Technol Cancer Res Treat; 2021; 20():15330338211041472. PubMed ID: 34569862
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC.
    Chen L; Liang Z; Tian Q; Li C; Ma X; Zhang Y; Yang Z; Wang P; Li Y
    J Exp Clin Cancer Res; 2011 Feb; 30(1):18. PubMed ID: 21306606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM11 expression in non-small cell lung cancer is associated with poor prognosis.
    Kuempers C; Jagomast T; Paulsen FO; Heidel C; Bohnet S; Schierholz S; Reischl M; Dreyer E; Olchers T; Reck M; Kirfel J; Perner S
    Histol Histopathol; 2024 Apr; 39(4):437-446. PubMed ID: 37409491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression.
    Sheng KL; Kang L; Pridham KJ; Dunkenberger LE; Sheng Z; Varghese RT
    Sci Rep; 2020 Dec; 10(1):21246. PubMed ID: 33277589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel.
    Xue VW; Ng SSM; Tsang HF; Wong HT; Leung WW; Wong YN; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Tai WCS; Wong SCC
    Clin Exp Med; 2023 Oct; 23(6):2421-2432. PubMed ID: 36637582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free SLC30A10 messenger ribonucleic acid (mRNA) expression and their association with vitamin-D level among non-small cell lung cancer (NSCLC) patients.
    Verma AK; Naseeb MA; Basaqr RO; Albajri EA; Khan MI; Dev K; Beg MMA
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S764-S769. PubMed ID: 38384053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying candidate diagnostic markers for early stage of non-small cell lung cancer.
    Wu Z; Zhang X; He Z; Hou L
    PLoS One; 2019; 14(11):e0225080. PubMed ID: 31726467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer.
    Cheng C; Nguyen TT; Tang M; Wang X; Jiang C; Liu Y; Gorlov I; Gorlova O; Iafrate J; Lanuti M; Christiani DC; Amos CI
    J Thorac Oncol; 2023 Sep; 18(9):1184-1198. PubMed ID: 37146750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.